At the news
? BULLISHIMPACT 7/10 PRESS-RELEASE filed Nov 10, 2026 at 16:01 ET
Freenome reported Q3 2026 total revenue of $183.5M, far above the $84.9M consensus, driven by a $100M milestone payment from Abbott following FDA approval of SimpleScreen CRC. GAAP net income swung to $60.1M from a loss of $64.5M a year ago. The company guided full-year 2026 revenue to $192M-$194M.
- Total revenue $183.5M vs consensus $84.9M, driven by $182.5M in license and collaboration revenue including a $100M milestone from Abbott
- GAAP net income $60.1M vs net loss of $64.5M in Q3 2025
- Adjusted EBITDA $117.9M vs negative $56.3M in Q3 2025
- Cash and marketable securities $430.0M as of September 30, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access